What’s New in Immunotherapy and Melanoma? [Webchat]

Cancer immunotherapy is a kind of cancer treatment that mobilizes the patient’s immune defenses to recognize and attack tumor cells. It is now the treatment of choice for many patients with advanced melanoma, according to Elizabeth I. Buchbinder, MD, a melanoma specialist at Dana-Farber.

“Immunotherapy has taken off,” Buchbinder says, “There are tons of areas where it is being developed, as well as some where it really has entered into the mainstream for cancer care.”

Buchbinder is interested in the potential of using immunotherapy to prevent reoccurrence of melanoma in patients.

“This is an area that’s very active right now,” Buchbinder says, “We’re really hopeful that we can use these drugs to lower the risk of melanoma coming back.”

Buchbinder discussed other developments in immunotherapy research and melanoma in a recent Facebook Live webchat. View the video below.

Learn more about melanoma treatment and research from the Center for Melanoma Oncology at Dana Farber/Brigham and Women’s Cancer Center.

Comments Sort By Newest

Leave a Reply

Your email address will not be published. Required fields are marked *

Blue Captcha Image
Refresh

*

Make An Appointment

For adults: 877-442-3324

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Statement from Dana-Farber on House Health Plan: https://t.co/z0yMKmAS3W
Dana-Farber @danafarber
Our Yawkey Center for Cancer Care features more than 500 works of art by artists like Andy Warhol. Take a tour:… https://t.co/fSYIuerZ5y
Dana-Farber @danafarber
For 17 girls & patients @ChildCancerCare, Dana-Farber’s annual Girls Weekend is an opportunity to relax & socialize… https://t.co/Jzh3th3TG0

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.